Influence of cardiac rehabilitation on natriuretic peptides

Angel Montiel-Trujillo1, Guillermo Isasti-Aizpurua, Fernando Carrasco-Chinchilla

  • 1Cardiology Department, Hospital Clinico Universitario Virgen de la Victoria, Malaga, Spain.

Acta Cardiologica
|October 29, 2011
PubMed

Insights

Cardiac rehabilitation improves functional capacity, with N-terminal pro-brain natriuretic peptide (NT-proBNP) levels rising during exercise. Higher baseline NT-proBNP indicates greater functional recovery, suggesting its utility in patient selection for cardiac rehab.

Area of Science:

  • Cardiology
  • Biomarkers
  • Exercise Physiology

Background:

  • Cardiac rehabilitation programs are proven to reduce morbidity and mortality.
  • The behavior of natriuretic peptides during these programs is not well understood.
  • N-terminal pro-brain natriuretic peptide (NT-proBNP) is a key biomarker in cardiovascular disease.

Purpose of the Study:

  • To investigate the changes in NT-proBNP levels in patients undergoing cardiac rehabilitation.
  • To correlate NT-proBNP levels with functional capacity improvements.
  • To assess the utility of NT-proBNP in patient selection for cardiac rehabilitation.

Main Methods:

  • Eighty-three moderate to high-risk patients were enrolled in a cardiac rehabilitation program.
  • NT-proBNP levels were measured four times: on the first and last day, before and after training.
  • Functional capacity was assessed using stress tests before and after the program.

Main Results:

  • Exercise led to increased NT-proBNP levels, with a diminished rise by the final session.
  • Patients with left ventricular dysfunction exhibited higher NT-proBNP levels.
  • A significant average functional capacity improvement of 1.5 METS was observed post-rehabilitation.

Conclusions:

  • NT-proBNP levels increase with exercise, particularly in patients with left ventricular dysfunction.
  • Higher baseline NT-proBNP levels correlated with greater functional recovery.
  • NT-proBNP measurement may aid in selecting appropriate candidates for cardiac rehabilitation programs.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: